- Breaking News San Mateo County ninth-graders struggle to stay fit
- Breaking News Food and wine events
- Breaking News Ask Amy: What To Do When the Doctor Isn t in the House
- Breaking News Ed Blonz: Keep your diet normal pre-surgery
Schering net profit up in first quarter
0 Comments | AFP, April, 2006
BERLIN (AFP) — Schering, the German pharmaceuticals specialist, has said that strong demand for its best-selling multiple sclerosis drug Betaferon and its Yasmin contraceptive pill boosted earnings in the first three months of the current year.
Schering, currently being taken over by bigger rival Bayer, said in a statement that bottom-line profits rose by 21 percent to 174 million euros (215 million dollars) in the period from January to March.
Operating profit was up four percent at 240 million euros on a 16-percent rise in sales to 1.406 billion euros, the statement said.
"Betaferon and Yasmin were the main growth drivers," Schering said.
"The excellent first-quarter figures will propel us towards reaching the goals we have set ourselves for 2006,"...
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Industry Experts Launch Money Management Resources to Help People Overcome Debt and Learn Proper Money Management Practices
- Portfolio forecasting tools: what you need to know
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- Banking technology, technological learning and competition: comparative case studies in Thai banking
- John Seely Brown Inducted Into 2004 Industry Hall of Fame
- A multi-class SVM classifier utilizing binary decision tree